Hussman Strategic Advisors’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,250
Closed -$22.2K 234
2023
Q3
$22.2K Buy
+5,250
New +$22.2K ﹤0.01% 290